Neutrogena "Renova compatible" skin care products to reach stores in April.
This article was originally published in The Tan Sheet
Executive Summary
NEUTROGENA SKIN CARE LINE, REPOSITIONED AS "RENOVA COMPATIBLE," will reach mass market outlets in April, according to the Johnson & Johnson personal care subsidiary. Launch of the line will follow closely the February introduction of the prescription antiwrinkling drug Renova by J&J subsidiary Ortho Pharmaceutical. Renova (tretinoin emollient cream .05%) was approved by FDA Dec. 29 ("The Tan Sheet" Jan. 8, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning